Medical research

Optimized vitamin K2 helps to treat osteoporosis

Osteoporosis is a common debilitating bone disease, which is characterized by bone loss and degeneration of bone structure, primarily caused by an imbalance between bone formation by osteoblasts and bone resorption by osteoclasts. ...

Diseases, Conditions, Syndromes

New osteoporosis therapy's dual effects on bone tissue

Sclerostin is a protein produced by osteocytes in the bone that inhibits bone formation. A recent analysis of results from a clinical trial reveals the beneficial effects of romosozumab, an antibody therapy that targets sclerostin, ...

Gerontology & Geriatrics

Individualized therapy for patients with osteoporosis

More than six million people in Germany suffer from osteoporosis. The disease is characterized by chronic bone resorption, leading to frequent fractures as a consequence of the bone loss. In many cases, treating the condition ...

page 1 from 6